Filter results
10/07/2025
Final Decision to award aid of 36.3 million euros for ROVI’s LAISOLID project subsidised by the CDTI
The beneficiary project, LAISOLID, focuses on developing new sterile filling technologies for polymeric matrices and new methodologies to accelerate the development of medicines based on predictive models
18/06/2025
ROVI distributes dividends of 48 million euros and approves all the items on the agenda at its General Shareholders’ Meeting by a wide margin
08/05/2025
ROVI ACHIEVED EBITDA GROWTH OF 17%
08/05/2025
The beneficiary project, LAISOLID, focuses on developing new sterile filling technologies for polymeric matrices and new methodologies to accelerate the development of medicines based on predictive models
25/03/2025
ROVI lays the foundations for its future growth: it forecasts that its contract manufacturing business sales will double by 2030
25/02/2025
ROVI ACHIEVED REVENUE OF 764.6 MILLION EUROS AND INCREASED ITS GROSS MARGIN BY 3.7 PERCENTAGE POINTS